Source: INFERRED ×
Variant Gene DSI v DPI v Chr Position Consequence Alleles Class AF EXOME AF GENOME Num. diseases
rs3184504
SH2B3 ; ATXN2
0.572 0.600 12 111446804 missense variant T/A;C;G snv 0.67 73
rs1260326
GCKR
0.645 0.600 2 27508073 missense variant T/C;G snv 0.63; 4.0E-06 0.68 64
rs780094
GCKR
0.658 0.400 2 27518370 intron variant T/C snv 0.67 43
rs964184
ZPR1
0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 38
rs4420638
APOC1
0.708 0.520 19 44919689 downstream gene variant A/G snv 0.18 36
rs1047891
CPS1
0.827 0.200 2 210675783 missense variant C/A snv 0.30 0.33 30
rs13107325
SLC39A8
0.776 0.520 4 102267552 missense variant C/A;T snv 4.0E-06; 4.5E-02 30
rs429358
APOE
0.590 0.600 19 44908684 missense variant T/C snv 0.14 0.16 28
rs9939609
FTO
0.559 0.720 16 53786615 intron variant T/A snv 0.41 25
rs2075650
TOMM40
0.662 0.360 19 44892362 intron variant A/G snv 0.13 0.13 25
rs79105258
CUX2
12 111280427 intron variant C/A;T snv 23
rs174547
FADS2 ; FADS1
0.742 0.240 11 61803311 intron variant T/C snv 0.28 23
rs10401969
SUGP1
0.776 0.240 19 19296909 intron variant T/C snv 0.10 23
rs7412
APOE
0.641 0.640 19 44908822 missense variant C/T snv 6.2E-02 7.9E-02 22
rs4803750
BCL3
0.807 0.240 19 44744370 upstream gene variant A/G snv 7.7E-02 22
rs629301
CELSR2
0.851 0.120 1 109275684 3 prime UTR variant G/T snv 0.74 22
rs1535
FADS2
0.752 0.240 11 61830500 intron variant A/G snv 0.31 22
rs1333049
CDKN2B-AS1
0.614 0.520 9 22125504 intron variant G/C snv 0.41 21
rs247617 0.827 0.160 16 56956804 regulatory region variant C/A snv 0.29 20
rs562338 0.807 0.160 2 21065449 intergenic variant A/G snv 0.69 20
rs261332
ALDH1A2 ; LIPC-AS1 ; LIPC
0.851 0.120 15 58435126 non coding transcript exon variant A/G snv 0.80 20
rs2074755
BAZ1B
0.807 0.240 7 73462836 non coding transcript exon variant T/C snv 9.2E-02 20
rs1728918 0.827 0.160 2 27412596 upstream gene variant A/G;T snv 19
rs12579302
ATP2B1
0.851 0.120 12 89656726 intron variant A/G snv 0.15 19
rs1800961
HNF4A
0.851 0.160 20 44413724 missense variant C/T snv 3.1E-02 2.5E-02 19